{"id":2168,"date":"2017-03-31T07:16:01","date_gmt":"2017-03-31T07:16:01","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=2168\/"},"modified":"2024-11-08T09:39:55","modified_gmt":"2024-11-08T09:39:55","slug":"efsa-consultation-guidance-identification-biological-relevance-adverse-effects","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/","title":{"rendered":"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies"},"content":{"rendered":"

The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies is opened until 1st May 2017.<\/p>\n

Generic issues and criteria are given to consider biological relevance, particularly when deciding on whether an observed effect is of biological relevance, i.e. is adverse (or shows a positive health effect) or not. The opinion clarifies a number of definitions and concepts, such as, responses of a biological system to exposure, mode of action and adverse outcome pathways, thresholds, critical effect, modelling approaches, etc. It also proposes several case studies.<\/p>\n

 <\/p>\n

<\/h6>\n

For more information:<\/strong> see EFSA website<\/a>.<\/p>\n

 <\/p>\n

Lynxee consulting\u2019s team<\/strong> is at your disposal to answer your questions.<\/p>\n

Contact us! https:\/\/lynxee.consulting\/en\/contact\/<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

<\/h6>\n
Photo credit: qimono\/pixabay<\/h6>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive health effects from experimental [\u2026]<\/span><\/p>\n","protected":false},"author":5,"featured_media":7636,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[164,143,58],"class_list":["post-2168","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-document-guide-en","tag-efsa","tag-guidance-document"],"yoast_head":"\nEFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-31T07:16:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-08T09:39:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1056\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Karine Mavet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karine Mavet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/\",\"url\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/\",\"name\":\"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\/\/lynxee.consulting\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg\",\"datePublished\":\"2017-03-31T07:16:01+00:00\",\"dateModified\":\"2024-11-08T09:39:55+00:00\",\"author\":{\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63\"},\"description\":\"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive\",\"breadcrumb\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage\",\"url\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg\",\"contentUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg\",\"width\":1920,\"height\":1056},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/lynxee.consulting\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lynxee.consulting\/#website\",\"url\":\"https:\/\/lynxee.consulting\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lynxee.consulting\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63\",\"name\":\"Karine Mavet\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg\",\"contentUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg\",\"caption\":\"Karine Mavet\"},\"sameAs\":[\"https:\/\/lynxee.consulting\"],\"url\":\"https:\/\/lynxee.consulting\/en\/author\/karine\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting","description":"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/","og_locale":"en_US","og_type":"article","og_title":"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting","og_description":"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive","og_url":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/","og_site_name":"Lynxee consulting","article_published_time":"2017-03-31T07:16:01+00:00","article_modified_time":"2024-11-08T09:39:55+00:00","og_image":[{"width":1920,"height":1056,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg","type":"image\/jpeg"}],"author":"Karine Mavet","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Karine Mavet","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/","url":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/","name":"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg","datePublished":"2017-03-31T07:16:01+00:00","dateModified":"2024-11-08T09:39:55+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63"},"description":"The public consultation on the draft guidance document of the EFSA Scientific Committee on the identification of biological relevance of adverse\/ positive","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2017\/04\/question-mark-1872634_1920.jpg","width":1920,"height":1056},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/efsa-consultation-guidance-identification-biological-relevance-adverse-effects\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"EFSA Public consultation: Guidance for the identification of biological relevance of adverse\/ positive health effects from experimental animal and human studies"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/a2a6161ec6591c6ae990f836d8ae4f63","name":"Karine Mavet","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2015\/05\/karine-96x96.jpg","caption":"Karine Mavet"},"sameAs":["https:\/\/lynxee.consulting"],"url":"https:\/\/lynxee.consulting\/en\/author\/karine\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2168","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=2168"}],"version-history":[{"count":3,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2168\/revisions"}],"predecessor-version":[{"id":7639,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2168\/revisions\/7639"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/7636"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=2168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=2168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=2168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}